Details for 2013744805
Up to date per 05.04.2026
Actions
Details for 2013744805
Granted/Registered
European Patent
08.04.2015 A
07.12.2016 B1
04.06.2012
EP
12170748
11.03.2013
EP
13158520
C07D 403/14 20060101AFI20151211BHEP
Owner
Idorsia Pharmaceuticals LtdHegenheimermattweg 91 4123 AllschwilCH
Representative
Representative
Dr. Müllner Dipl.-Ing. Katschinka OG, PatentanwaltskanzleiWeihburggasse 91010 WienAT
Inventor
BOSS, Christophc/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 4123 AllschwilCH
BROTSCHI, Christinec/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 4123 AllschwilCH
GUDE, MarkusGrabenring 9 4123 AllschwilCH
HEIDMANN, Bibiac/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 4123 AllschwilCH
SIFFERLEN, Thierryc/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 4123 AllschwilCH
WILLIAMS, Jodi T.c/o Actelion Pharmaceuticals Ltd Gewerbestrasse 16 4123 AllschwilCH
Information about Fees